SAN FRANCISCO – A drug-eluting resorbable scaffold showed superior efficacy and comparable safety to percutaneous transluminal angioplasty (PTA) in patients with chronic limb-threatening ischemia (CLTI) and infrapopliteal disease, new randomized controlled trial results show.